Hansen Shannon Marie 4

What Happened Shannon Marie Hansen, EVP & Chief Legal Officer of Tandem Diabetes Care, Inc. (TNDM), received a grant of 29,136 restricted stock units (RSUs) on 2026-05-29. The Form 4 reports the award as a derivative acquisition at $0.00 per unit (reported value $0 on the form). This is a grant/award (code A) — not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-29; filing date: 2026-06-02 (filed within the standard reporting window).
• Reported acquisition: 29,136 RSUs @ $0.00 (derivative award).
• Shares owned after the transaction: not specified in the provided filing summary.
• Footnote F1: Each RSU is a contingent right to receive one share of common stock or cash in lieu, at the issuer’s discretion, under the 2023 Long-Term Incentive Plan.
• Footnote F2: Vesting schedule — one‑third vests on 5/29/2027; the remaining RSUs vest in eight equal quarterly installments on the 15th of the month thereafter.
• Remarks: Ex. 24 (Power of Attorney) included with the filing.

Context RSU grants are compensation awards that convert to shares (or cash) only after vesting per the plan terms; they are not immediate purchases or sales. The Form 4 reports the grant itself (a derivative award), not a sale or exercise, and does not assign a market value on the filing. This filing is informational about executive compensation and does not, by itself, indicate buying or selling intent.